Filter posts

IPO Update - Jan 2012

2011 ended quietly for the US biotech IPO market. It has now been almost two …

Where's the Deal?

With only two weeks to go in 2011 it is looking like a five year …

Just how big is $11 Billion? GILD Acquires VRUS

Seeing the markets open down 2% or more on a Monday morning feels like “business …

Public Exits and Virtual Biotechs - Dreams or Reality?

Here at the 10th Annual BIO Investor Forum, investors and CEOs are debating “all the …

Perspective on Market Valuation for Biotech Drug Developers

Of the 300 publicly traded U.S. biotechs, 219 (73%) are developing drugs. The other 27% …

Biotech IPO Window - Still Ajar?

IPO plans for Quark Pharmaceuticals were officially put on hold last week as markets continue …

Biotech IPO Update for May 18th, 2011

There are now eight biotech IPOs for 2011, bringing the total for the recent US …

Nasdaq Biotech Index re-ranking for next Monday

Twice a year, in May and November, the NASDAQ OMX Group re-ranks the closely watched …

IPO Update - April 5th, 2011

The six biotech IPOs of 2011 have followed 2010’s IPO trends; all took significant haircuts getting …

The BTK buyout

Remember this BTK post we wrote back  in February of 2010?  Well, we thought it was time …